The Efficacy of Sodium Benzoate as an Adjunctive Treatment in Early Psychosis
This study is completed. It focuses on schizophrenia and currently lists study information in Australia.
Schizophrenia, BipolarityDrugFrom 15 Years to 45 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What the source says
The registry describes this research topic: “The Efficacy of Sodium Benzoate as an Adjunctive Treatment in Early Psychosis”. This is an interventional study. The registry lists a target sample size of 100. Recruitment status at the registry update of 2019-07-31: completed. Read the original description and eligibility criteria, and confirm the practical details with the study team.
What should you check before joining?
Check the full criteria in the official source. Ask the team to confirm recruitment, locations, visits, risks and participation requirements.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Australia · 9 sites
Royal Brisbane & Womens Hospital
Herston
Site status: Not listed — confirm with the team
Ipswich Hospital
Ipswich
Site status: Not listed — confirm with the team
The Prince Charles Hospital
Chermside
Site status: Not listed — confirm with the team
Gold Coast Hospital
Southport
Site status: Not listed — confirm with the team
Lady Cilento Children's Hospital
South Brisbane
Site status: Not listed — confirm with the team
Logan Hospital
Meadowbrook
Site status: Not listed — confirm with the team
Princess Alexandra Hospital
Woolloongabba
Site status: Not listed — confirm with the team
Sunshine Coast University Hospital
Birtinya
Site status: Not listed — confirm with the team
Caboolture Hospital
Caboolture
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study. Phase 4 studies usually happen after treatment approval, to monitor real-world use.
Who might this study be for?
This study may concern people with schizophrenia; age range: From 15 Years to 45 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
Does a loved one or caregiver need to be involved?
The public registry appears to mention a loved one, caregiver, or family involvement. Ask whether that person must participate, provide information, attend visits, or simply be available if needed. The study team must confirm what is required.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by The University of Queensland, which appears to be a university. The listed contact or investigator is John McGrath. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.